135 related articles for article (PubMed ID: 2106004)
1. Free and antibody-complexed antigen and antibody profile in apparently healthy HIV seropositive individuals and in AIDS patients.
Portera M; Vitale F; La Licata R; Alesi DR; Lupo G; Bonura F; Romano N; Di Cuonzo G
J Med Virol; 1990 Jan; 30(1):30-5. PubMed ID: 2106004
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 neutralizing antibodies in urine from seropositive individuals.
Cao YZ; Friedman-Kien AE; Mirabile M; Li XL; Alam M; Dieterich D; Ho DD
J Acquir Immune Defic Syndr (1988); 1990; 3(3):195-9. PubMed ID: 1968094
[TBL] [Abstract][Full Text] [Related]
3. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
[TBL] [Abstract][Full Text] [Related]
4. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
5. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
Thomas HI; Wilson S; O'Toole CM; Lister CM; Saeed AM; Watkins RP; Morgan-Capner P
Clin Exp Immunol; 1996 Feb; 103(2):185-91. PubMed ID: 8565298
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of antibodies against HIV-1 proteins in seropositive drug addicts tested by the western blotting method].
Swiderska H; Kalinowska B
Przegl Epidemiol; 1992; 46(1-2):19-25. PubMed ID: 1475386
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of specific antibodies to human immunodeficiency virus structural proteins: clinical significance.
Allain JP; Laurian Y; Einstein MH; Braun BP; Delaney SR; Stephens JE; Daluga CK; Dahlen SJ; Knigge KM
Blood; 1991 Mar; 77(5):1118-23. PubMed ID: 1671648
[TBL] [Abstract][Full Text] [Related]
9. Discriminating between protective and enhancing HIV antibodies.
Bernard J; Reveil B; Najman I; Liautaud-Roger F; Fouchard M; Picard O; Cattan A; Mabondzo A; Laverne S; Gallo RC
AIDS Res Hum Retroviruses; 1990 Feb; 6(2):243-9. PubMed ID: 2109624
[TBL] [Abstract][Full Text] [Related]
10. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count.
Eyster ME; Ballard JO; Gail MH; Drummond JE; Goedert JJ
Ann Intern Med; 1989 Jun; 110(12):963-9. PubMed ID: 2567142
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of HIV: correlation with clinical, virological, and immunological status.
O'Shea S; Rostron T; Hamblin AS; Palmer SJ; Banatvala JE
J Med Virol; 1991 Sep; 35(1):65-9. PubMed ID: 1940886
[TBL] [Abstract][Full Text] [Related]
12. Viral gene expression, antibody production and immune complex formation in human immunodeficiency virus infection.
Lange JM; Paul DA; de Wolf F; Coutinho RA; Goudsmit J
AIDS; 1987 May; 1(1):15-20. PubMed ID: 3122785
[TBL] [Abstract][Full Text] [Related]
13. Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.
Reiss P; de Wolf F; Kuiken CL; de Ronde A; Dekker J; Boucher CA; Debouck C; Lange JM; Goudsmit J
J Acquir Immune Defic Syndr (1988); 1991; 4(2):165-72. PubMed ID: 1898969
[TBL] [Abstract][Full Text] [Related]
14. Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41).
Filice G; Soldini L; Orsolini P; Razzini E; Chiapparoli L; Gulminetti R; Cattaneo E; Achilli G
Microbiologica; 1991 Jan; 14(1):1-7. PubMed ID: 1906127
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
16. Relationship between cell-free viraemia, antigenaemia and antibody levels in HIV-1-infected Ethiopian patients.
Ayehunie S; Sönnerborg A; Desta B; Kefene H; Zewdie D; Britton S; Strannegård O
AIDS; 1992 Jul; 6(7):651-7. PubMed ID: 1503684
[TBL] [Abstract][Full Text] [Related]
17. A 7-year analysis of anti-Gag (p17 and p24) antibodies in HIV-1-seropositive patients with haemophilia: immunoglobulin G titre and avidity are early predictors of clinical course.
Chargelegue D; Colvin BT; O'Toole CM
AIDS; 1993 Nov; 7 Suppl 2():S87-90. PubMed ID: 7909231
[TBL] [Abstract][Full Text] [Related]
18. Appearance of predictors of disease progression in relation to the development of AIDS.
de Wolf F; Lange JM; Houweling JT; Mulder JW; Beemster J; Schellekens PT; Coutinho RA; van der Noordaa J; Goudsmit J
AIDS; 1989 Sep; 3(9):563-9. PubMed ID: 2571348
[TBL] [Abstract][Full Text] [Related]
19. Predictive markers of AIDS: a follow-up of lymphocyte subsets and HIV serology in a cohort of patients with lymphadenopathy.
Böttiger B; Morfeldt-Månson L; Putkonen P; Nilsson B; Julander I; Biberfeld G
Scand J Infect Dis; 1989; 21(5):507-14. PubMed ID: 2511625
[TBL] [Abstract][Full Text] [Related]
20. Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay.
Busch MP; el Amad Z; McHugh TM; Chien D; Polito AJ
Transfusion; 1991 Feb; 31(2):129-37. PubMed ID: 1899951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
